Biologics Distributor for Medspas and Aesthetic Practices in Lafayette, LA

What Medspas and Aesthetic Practices Ask Before Adding a New Vendor

Medspas and aesthetic or dermatology practices evaluating a biologics distributor generally want to know who processes the product, how lots are tested, and whether the supplier will stand behind documentation if a state board or auditor asks for it. Some practices also ask how quickly a distributor can produce updated documentation if a lot's testing results are requested by an accrediting body.

Precision Biologics is a master distributor, not the processor; we can tell a Lafayette practice exactly which records we hold for each lot of Wharton's jelly or exosome product and which questions belong to the original supplier.

Account Verification and Ordering

Every order runs through an NPI-verified account. Because Precision Biologics sells only to licensed clinics and physician-supervised medspas, a practice manager setting up a new account should have the supervising physician's NPI on hand.

Pricing is available to verified accounts rather than published, consistent with how most biologics distributors handle wholesale pricing for licensed buyers.

Shipping, Storage, and Documentation

Cryopreserved Wharton's jelly formats ship overnight on dry ice and require prompt transfer to -80 degree C storage. Our lyophilized exosome and Wharton's jelly formats are shelf-stable under normal storage, which some Lafayette medspas prefer if they do not keep an ultra-low freezer on site.

Each lot ships with a unique identifier and documentation, including a certificate of analysis, available on request. Because these are not FDA-approved or licensed for any disease or condition, we recommend the supervising physician confirm their intended use with the Louisiana medical board and independent counsel. Retaining these records alongside other allograft or injectable documentation already on file can simplify any later review.

FDA has stated there are no FDA-approved exosome products. Exosome products are generally regulated as biologic drugs under section 351 of the Public Health Service Act, not as 361 HCT/Ps. Purchase and clinical use decisions belong to the physician with their own regulatory counsel.

These products are not FDA approved or licensed for any disease or condition. Information is for licensed healthcare professionals and is not medical or legal advice.